Home > Startup Directory >

Loyal

Last Updated

July 14, 2023

Loyal

A clinical-stage veterinary medicine company on a mission to help dogs live longer, healthier lives.

About

Industry

Biotech, Pets

Founded

2019

Headquarters

San Francisco, California

Website

jobs

Funding History

funding

$58 million

Valuation

Undisclosed

Notable investors

Khosla Ventures, First Round Capital, The Longevity Fund, Lachy Groom, BoxGroup, Collab Fund

Traction

Loyal’s team has published 152 papers, worked on 56 clinical drug programs, and combined for 192 years of research.

Loyal received protocol concurrence from the FDA for its companion dog longevity study.

Leadership

Celine Halioua: Founder of Loyal. Former Chief of Staff at The Longevity Fund.

Stacy Ross: VP, CMC at Loyal. Former Director, CMC Project Lead at Sage Therapeutics.

Dina Juarez-Salinas, PhD: VP of Preclinical Development at Loyal. Former Scientist at CODA Biotherapeutics.

Karen Greenwood: SVP, Regulatory, and Strategy at Loyal. Former VP of Product Management at Kindred Biosciences.‍

John Poisson: Chief Creative Officer at Loyal. Former Founder & CEO of Wantful.

Latest News

Longevity Technology (March 10, 2023): First longevity clinical study design fetches FDA approval

Wired (October 13, 2022): The Search for a Pill That Can Help Dogs—and Humans—Live Longer

TechCrunch (September 23, 2021): Loyal raises $27M, aims to give dog owners more time with their pets